P4–268: Pharmacokinetics and pharmacodynamics of CHF5022 and CHF5074, two new β–amyloid1–42 lowering agents, after multiple doses in TG2576 transgenic mice

作者
Bruno Pietro Imbimbo,Elda Del Giudice,Valentina Cenacchi,Gino Villetti,Fabrizio Facchinetti,Alberta Leon
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:2 (3S_Part_19)
标识
DOI:10.1016/j.jalz.2006.05.2007
摘要

Long–term use of non–steroidal anti–inflammatory drugs (NSAIDs) may delay or prevent the onset of AD. A subset of NSAIDs, including flurbiprofen, has been shown to selectively inhibit the production of β–amyloid1–42 (Aβ42), independently from their cyclooxygenase (COX) inhibiting activity. CHF5022 and CHF5074 are two new flurbiprofen analogues with potent and selective inhibitory activity on Aβ42 and devoid of anti–COX activity. To evaluate the pharmacokinetics and pharmacodynamics of CHF5022 and CHF5074 after multiple dosing in a transgenic mice model of AD (Tg2576). Tg2576 mice were treated with CHF5022 or CHF5074 up to 4–weeks. Drugs were administered either by oral gavage (up to 300 mg/kg/day) or by medicated diet (375 ppm). R–flurbiprofen was used as comparator. R–flurbiprofen was poorly tolerated both at the dose of 25 mg/kg/day by oral gavage for 1 week and in the diet for 4 weeks (32 mg/kg/day) with 25–55% of animals dying during the first days of treatment. CHF5022 and CHF5074 were well tolerated after both oral dosing (up to 300 mg/kg/day) and after medicated diet (50–60 mg/kg/day) with body weight and mortality being similar to controls. CHF5022 and CHF5074 plasma and brain levels were found to increase with the dose. After 5 days of oral gavage, CHF5022 and CHF5074 brain levels at 3 hours were 11% and 5% of corresponding plasma concentrations. After 4 weeks in the diet, CHF5022 reached mean plasma concentrations at 3 hours of 9403 μg/mL in plasma and 294 μg/g in brain, levels 15–20 times higher than those reached with R–flurbiprofen. Plasma Aβ42 concentrations were dose–dependently suppressed by CHF5022 and CHF5074. Brain Aβ42, but not Aβ40, concentrations tended to inversely correlate with brain CHF5022 levels. In Tg2576 mice, multiple doses of CHF5022 and CHF5074 appeared to be better tolerated than R–flurbiprofen. The two drugs showed much higher systemic exposure and brain penetration than R–flurbiprofen. We collected encouraging evidences of in vivo pharmacological activity of CHF5022 and CHF5074 after short–term administration in a transgenic mouse model of AD. The effects of long–term administration of CHF5022 and CHF5074 on cerebral Aβ pathology in transgenic mice are being assessed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YiRan发布了新的文献求助10
刚刚
追寻惜萱完成签到 ,获得积分10
刚刚
WhaleHu完成签到,获得积分10
刚刚
李健的应助被电生理搬运工采纳,获得10
1秒前
kyscro发布了新的文献求助10
1秒前
单薄冰安发布了新的文献求助10
1秒前
可爱的函函的应助被之之采纳,获得10
1秒前
祓木完成签到,获得积分10
2秒前
2秒前
3秒前
元元关注了科研通微信公众号
4秒前
5秒前
飞翔完成签到,获得积分10
5秒前
斯文败类的应助被啵子采纳,获得10
5秒前
5秒前
小二郎的应助被踏实凡桃采纳,获得10
6秒前
6秒前
111发布了新的文献求助10
6秒前
Hello的应助被conniechen采纳,获得10
6秒前
xx发布了新的文献求助10
7秒前
华仔的应助被开心德地采纳,获得10
7秒前
小马甲的应助被wg采纳,获得10
8秒前
KK完成签到,获得积分10
8秒前
9秒前
君澔发布了新的文献求助10
10秒前
我是谁完成签到,获得积分20
11秒前
沐沐发布了新的文献求助10
11秒前
小杨完成签到,获得积分10
11秒前
合法的天空完成签到,获得积分10
12秒前
12秒前
Zz发布了新的文献求助200
12秒前
大胆的马里奥完成签到,获得积分10
13秒前
水煮电吹风的应助被萧笙采纳,获得10
14秒前
橙巧巧和乌霉霉完成签到,获得积分10
16秒前
17秒前
17秒前
18秒前
甘甚么完成签到,获得积分10
19秒前
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188654
求助须知:如何正确求助?哪些是违规求助? 9576372
关于积分的说明 21847161
捐赠科研通 7786741
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360